• VOLUNTARY ANNOUNCEMENT - STRATEGIC COOPERATION AGREEMENT WITH JENSCARE SCIENTIFIC

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022

   

• VOLUNTARY ANNOUNCEMENT - Enrollment in the China Randomized Controlled Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2022

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2022

   

• VOLUNTARY ANNOUNCEMENT - Admission of Innovative Medical Devices in respect of Aortic Arch Stent Graft System (Fenestration) into Special Examination and Approval Procedure

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2022

   

• FDA Approved Investigator-initiated Pre-market Clinical Trial of LAmbreTM Plus LAA Closure System Obtained Medical Insurance Coverage in the US

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2022